Search
for
Sort by
Research 91–120 of 168
- Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Cutaneous side-effects of EGFR inhibitors and their management.
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin
- Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management.
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Drugs linked to blepharitis, meibomian gland dysfunction, and chalazion: a real-world, population-based pharmacovigilance analysis
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Targeted Self-Assembled anti-NFκB AuNCs-Aptamer Nanoplatform for Precise Theranostics via Tailored Follicle Regeneration
- Massive squamous cell carcinoma arising from hidradenitis suppurativa with marked hypercalcemia and neutrophilia
- Malassezia Folliculitis
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- “Sebocytes’ makeup” - Novel mechanisms and concepts in the physiology of the human sebaceous glands
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Poliosis circumscripta: Overview and underlying causes
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Madarosis: A marker of many Maladies
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- The influence of interferon on healthy and diseased skin
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Distinct transcriptomic landscapes of cutaneous basal cell carcinomas and squamous cell carcinomas
- Neural progenitor cell-derived nanovesicles promote hair follicle growth via miR-100